Clinical trials
Recruiting Phase 1/2 Prostatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 15 |
| 2025 | 22 |
| 2026 | 17 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 74 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| First Affiliated Hospital of Fujian Medical University | 3 |
| Jiangsu HengRui Medicine Co., Ltd. | 3 |
| M.D. Anderson Cancer Center | 3 |
| The Methodist Hospital Research Institute | 3 |
| Essen Biotech | 2 |
| GlaxoSmithKline | 2 |
| National Cancer Institute (NCI) | 2 |
| SpectraCure AB | 2 |
| 858 Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 74 |
| Breast Neoplasms | 16 |
| Ovarian Neoplasms | 15 |
| Pancreatic Neoplasms | 13 |
| Colorectal Neoplasms | 9 |
| Neoplasm Metastasis | 8 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Endometrial Neoplasms | 7 |
| Head and Neck Neoplasms | 6 |
| Neoplasms | 6 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.